Cisgen Biotech Discoveries Private LIMITED
Chennai, TN
- UEI
- VWPHAA4FL299
- CAGE
- 3292Y
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 4, Chennai Tiruvallur High Rd, Padi, Chennai, Tamil Nadu 600050, India
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Pennsylvania State University | R01AI170753 | $110,075 | |
| The Pennsylvania State University | R01AI170753 | $46,766 | |
| The Pennsylvania State University | HDTRA12110030 | $282,123 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Nivedi | Bengaluru, KA | — |
| Sino Biological US Inc. | Paoli, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Infinity Bio, Inc. | Baltimore, MD | 541380 Testing Laboratories and Services |
| Mirimus, Inc. | NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Ampersand Biosciences LLC | Lake Clear, NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Cisgen Biotech Discoveries Private LIMITED is a for-profit, woman-owned business providing scientific research and consulting services. Registered in SAM.gov since September 2019 with an active registration through September 2024, Cisgen Biotech collaborates with universities and other organizations on federal grants related to molecular biology and epidemiology research.
Cisgen Biotech Discoveries has received multiple federal subaward grants to collaborate with The Pennsylvania State University on a project titled "One Health Approach for Molecular Epidemiology and Risk Assessment for Bacillus Anthracis in India." As a subawardee, Cisgen Biotech likely provides specialized expertise and services to support the prime grantee's molecular biology and epidemiology research on Bacillus Anthracis transmission. Based on the project title and Cisgen Biotech's status as a biotechnology consulting firm, their subawards under this project likely fund ongoing scientific research and advisory services relevant to the overall project goals of assessing anthrax molecular epidemiology and transmission risk in India.
Quick answers
Is Cisgen Biotech Discoveries Private LIMITED registered in SAM.gov?
Yes. Cisgen Biotech Discoveries Private LIMITED's SAM.gov registration is active through July 14, 2027.
On GovTribe
See Cisgen Biotech Discoveries Private LIMITED's full federal record
- Similar vendors